AAFA's Advocacy for Health Equity Leads to White House Address on Asthma Inhaler Pricing Washington, DC, April 03, 2024 (GLOBE NEWSWIRE) -- As the leading advocacy organization focused on improving the access and affordability of asthma inhalers, the Asthma and Allergy Foundation of...

AAFA Statement in Response to AstraZeneca Asthma Inhaler Cost Announcement Washington, DC, March 18, 2024 (GLOBE NEWSWIRE) -- The Asthma and Allergy Foundation of America (AAFA) welcomes efforts to make asthma medicines more affordable and accessible. AAFA continues to...

AAFA Applauds Senate Investigation into Pricing of Asthma Inhalers Washington, DC, Jan. 09, 2024 (GLOBE NEWSWIRE) -- The Asthma and Allergy Foundation of America (AAFA) today applauded the announcement of a U.S. Senate Committee on Health, Education, Labor, and...